> top > projects > spacy-test > docs > PubMed:3924667 > annotations
spacy-test Home  

PubMed:3924667 JSONTXT 3 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
spaCy_T0 0-12 NNP denotes Gonadotropin
spaCy_T1 13-22 NN denotes secretion
spaCy_T2 23-29 IN denotes before
spaCy_T3 30-33 CC denotes and
spaCy_T4 34-40 IN denotes during
spaCy_T5 41-46 JJ denotes acute
spaCy_T6 47-50 CC denotes and
spaCy_T7 51-58 JJ denotes chronic
spaCy_T8 59-76 NN denotes dopamine-receptor
spaCy_T9 77-85 NN denotes blockade
spaCy_T10 86-88 IN denotes in
spaCy_T11 89-106 JJ denotes insulin-dependent
spaCy_T12 107-115 NN denotes diabetic
spaCy_T13 116-124 NNS denotes patients
spaCy_T14 125-129 IN denotes with
spaCy_T15 130-140 NN denotes amenorrhea
spaCy_T16 140-141 . denotes .
spaCy_T17 142-145 DT denotes The
spaCy_T18 146-158 JJ denotes dopaminergic
spaCy_T19 159-168 NN denotes influence
spaCy_T20 169-171 IN denotes on
spaCy_T21 172-183 VBG denotes luteinizing
spaCy_T22 184-191 NN denotes hormone
spaCy_T23 192-193 -LRB- denotes (
spaCy_T24 193-195 NNP denotes LH
spaCy_T25 195-196 -RRB- denotes )
spaCy_T26 196-197 , denotes ,
spaCy_T27 198-218 JJ denotes follicle-stimulating
spaCy_T28 219-226 NN denotes hormone
spaCy_T29 227-228 -LRB- denotes (
spaCy_T30 228-231 NNP denotes FSH
spaCy_T31 231-232 -RRB- denotes )
spaCy_T32 232-233 , denotes ,
spaCy_T33 234-237 CC denotes and
spaCy_T34 238-247 NN denotes prolactin
spaCy_T35 248-249 -LRB- denotes (
spaCy_T36 249-252 NNP denotes PRL
spaCy_T37 252-253 -RRB- denotes )
spaCy_T38 254-257 VBD denotes was
spaCy_T39 258-265 VBN denotes studied
spaCy_T40 266-268 IN denotes in
spaCy_T41 269-271 CD denotes 12
spaCy_T42 272-280 NN denotes diabetic
spaCy_T43 281-289 NNS denotes patients
spaCy_T44 290-294 IN denotes with
spaCy_T45 295-305 NN denotes amenorrhea
spaCy_T46 306-307 -LRB- denotes (
spaCy_T47 307-311 NNP denotes DMAM
spaCy_T48 311-312 -RRB- denotes )
spaCy_T49 313-316 CC denotes and
spaCy_T50 317-319 IN denotes in
spaCy_T51 320-322 CD denotes 10
spaCy_T52 323-329 JJ denotes normal
spaCy_T53 330-342 NN denotes menstruating
spaCy_T54 343-351 NN denotes diabetic
spaCy_T55 352-360 NNS denotes patients
spaCy_T56 361-362 -LRB- denotes (
spaCy_T57 362-364 NNP denotes DM
spaCy_T58 364-365 -RRB- denotes )
spaCy_T59 365-366 . denotes .
spaCy_T60 367-371 NNP denotes DMAM
spaCy_T61 372-380 NNS denotes patients
spaCy_T62 381-384 VBD denotes had
spaCy_T63 385-386 DT denotes a
spaCy_T64 387-396 NN denotes reduction
spaCy_T65 397-399 IN denotes in
spaCy_T66 400-402 NNP denotes LH
spaCy_T67 403-414 NN denotes pulsatility
spaCy_T68 415-416 -LRB- denotes (
spaCy_T69 416-417 NNP denotes P
spaCy_T70 418-422 JJR denotes less
spaCy_T71 423-427 IN denotes than
spaCy_T72 428-432 CD denotes 0.05
spaCy_T73 432-433 -RRB- denotes )
spaCy_T74 434-437 CC denotes and
spaCy_T75 438-443 JJ denotes basal
spaCy_T76 444-446 NNP denotes LH
spaCy_T77 447-453 NNS denotes levels
spaCy_T78 454-455 -LRB- denotes (
spaCy_T79 455-456 NNP denotes P
spaCy_T80 457-461 JJR denotes less
spaCy_T81 462-466 IN denotes than
spaCy_T82 467-471 CD denotes 0.02
spaCy_T83 471-472 -RRB- denotes )
spaCy_T84 472-473 , denotes ,
spaCy_T85 474-482 VBN denotes compared
spaCy_T86 483-487 IN denotes with
spaCy_T87 488-490 NNP denotes DM
spaCy_T88 491-499 NNS denotes patients
spaCy_T89 499-500 , denotes ,
spaCy_T90 501-508 IN denotes whereas
spaCy_T91 509-513 PRP denotes they
spaCy_T92 514-517 VBD denotes had
spaCy_T93 518-520 DT denotes an
spaCy_T94 521-523 NNP denotes LH
spaCy_T95 524-527 CC denotes and
spaCy_T96 528-531 NNP denotes FSH
spaCy_T97 532-540 NN denotes response
spaCy_T98 541-543 TO denotes to
spaCy_T99 544-555 JJ denotes intravenous
spaCy_T100 556-570 NN denotes metoclopramide
spaCy_T101 571-572 -LRB- denotes (
spaCy_T102 572-575 NNP denotes MTC
spaCy_T103 575-576 -RRB- denotes )
spaCy_T104 577-579 IN denotes at
spaCy_T105 580-582 CD denotes 30
spaCy_T106 582-583 , denotes ,
spaCy_T107 584-586 CD denotes 45
spaCy_T108 586-587 , denotes ,
spaCy_T109 588-591 CC denotes and
spaCy_T110 592-594 CD denotes 60
spaCy_T111 595-602 NNS denotes minutes
spaCy_T112 603-606 CC denotes and
spaCy_T113 607-609 IN denotes at
spaCy_T114 610-612 CD denotes 30
spaCy_T115 613-620 NNS denotes minutes
spaCy_T116 620-621 , denotes ,
spaCy_T117 622-634 RB denotes respectively
spaCy_T118 635-636 -LRB- denotes (
spaCy_T119 636-637 NNP denotes P
spaCy_T120 638-642 JJR denotes less
spaCy_T121 643-647 IN denotes than
spaCy_T122 648-652 CD denotes 0.05
spaCy_T123 652-653 -RRB- denotes )
spaCy_T124 653-654 . denotes .
spaCy_T125 655-660 NNP denotes Basal
spaCy_T126 661-662 -LRB- denotes (
spaCy_T127 662-663 NNP denotes P
spaCy_T128 664-668 JJR denotes less
spaCy_T129 669-673 IN denotes than
spaCy_T130 674-678 CD denotes 0.05
spaCy_T131 678-679 -RRB- denotes )
spaCy_T132 680-683 CC denotes and
spaCy_T133 684-698 JJ denotes MTC-stimulated
spaCy_T134 699-700 -LRB- denotes (
spaCy_T135 700-701 NNP denotes P
spaCy_T136 702-706 JJR denotes less
spaCy_T137 707-711 IN denotes than
spaCy_T138 712-716 CD denotes 0.05
spaCy_T139 716-717 -RRB- denotes )
spaCy_T140 718-721 NNP denotes PRL
spaCy_T141 722-728 NNS denotes levels
spaCy_T142 729-733 VBD denotes were
spaCy_T143 734-739 JJR denotes lower
spaCy_T144 740-742 IN denotes in
spaCy_T145 743-747 NNP denotes DMAM
spaCy_T146 748-752 IN denotes than
spaCy_T147 753-755 IN denotes in
spaCy_T148 756-758 NNP denotes DM
spaCy_T149 759-767 NNS denotes patients
spaCy_T150 767-768 . denotes .
spaCy_T151 769-774 NNP denotes Serum
spaCy_T152 775-778 NNP denotes PRL
spaCy_T153 779-782 CC denotes and
spaCy_T154 783-786 NNP denotes FSH
spaCy_T155 787-796 VBD denotes increased
spaCy_T156 797-810 RB denotes significantly
spaCy_T157 811-812 -LRB- denotes (
spaCy_T158 812-813 NNP denotes P
spaCy_T159 814-818 JJR denotes less
spaCy_T160 819-823 IN denotes than
spaCy_T161 824-828 CD denotes 0.02
spaCy_T162 828-829 -RRB- denotes )
spaCy_T163 830-832 IN denotes in
spaCy_T164 833-836 CD denotes six
spaCy_T165 837-841 NNP denotes DMAM
spaCy_T166 842-850 NNS denotes patients
spaCy_T167 851-857 IN denotes during
spaCy_T168 858-860 CD denotes 10
spaCy_T169 861-866 NNS denotes weeks
spaCy_T170 867-869 IN denotes of
spaCy_T171 870-874 JJ denotes oral
spaCy_T172 875-878 NNP denotes MTC
spaCy_T173 879-893 NN denotes administration
spaCy_T174 893-894 , denotes ,
spaCy_T175 895-902 IN denotes whereas
spaCy_T176 903-905 DT denotes no
spaCy_T177 906-917 JJ denotes significant
spaCy_T178 918-919 -LRB- denotes (
spaCy_T179 919-920 NNP denotes P
spaCy_T180 921-928 JJR denotes greater
spaCy_T181 929-933 IN denotes than
spaCy_T182 934-938 CD denotes 0.05
spaCy_T183 938-939 -RRB- denotes )
spaCy_T184 940-951 NNS denotes alterations
spaCy_T185 952-960 VBD denotes occurred
spaCy_T186 961-963 IN denotes in
spaCy_T187 964-969 NN denotes serum
spaCy_T188 970-972 NNP denotes LH
spaCy_T189 973-976 CC denotes and
spaCy_T190 977-986 NN denotes estradiol
spaCy_T191 987-993 NNS denotes levels
spaCy_T192 993-994 . denotes .
spaCy_T193 995-1000 DT denotes These
spaCy_T194 1001-1005 NNS denotes data
spaCy_T195 1006-1011 NN denotes point
spaCy_T196 1012-1018 IN denotes toward
spaCy_T197 1019-1028 VBN denotes increased
spaCy_T198 1029-1041 JJ denotes dopaminergic
spaCy_T199 1042-1050 NN denotes activity
spaCy_T200 1051-1053 IN denotes in
spaCy_T201 1054-1058 NNP denotes DMAM
spaCy_T202 1059-1067 NNS denotes patients
spaCy_T203 1067-1068 . denotes .
spaCy_R0 spaCy_T0 spaCy_T1 compound Gonadotropin,secretion
spaCy_R1 spaCy_T1 spaCy_T1 ROOT secretion,secretion
spaCy_R10 spaCy_T10 spaCy_T9 prep in,blockade
spaCy_R100 spaCy_T100 spaCy_T98 pobj metoclopramide,to
spaCy_R101 spaCy_T101 spaCy_T102 punct (,MTC
spaCy_R102 spaCy_T102 spaCy_T100 appos MTC,metoclopramide
spaCy_R103 spaCy_T103 spaCy_T102 punct ),MTC
spaCy_R104 spaCy_T104 spaCy_T92 prep at,had
spaCy_R105 spaCy_T105 spaCy_T104 pobj 30,at
spaCy_R106 spaCy_T106 spaCy_T105 punct ",",30
spaCy_R107 spaCy_T107 spaCy_T105 conj 45,30
spaCy_R108 spaCy_T108 spaCy_T92 punct ",",had
spaCy_R109 spaCy_T109 spaCy_T92 cc and,had
spaCy_R11 spaCy_T11 spaCy_T13 amod insulin-dependent,patients
spaCy_R110 spaCy_T110 spaCy_T111 nummod 60,minutes
spaCy_R111 spaCy_T111 spaCy_T113 nsubj minutes,at
spaCy_R112 spaCy_T112 spaCy_T111 cc and,minutes
spaCy_R113 spaCy_T113 spaCy_T92 conj at,had
spaCy_R114 spaCy_T114 spaCy_T115 nummod 30,minutes
spaCy_R115 spaCy_T115 spaCy_T113 pobj minutes,at
spaCy_R116 spaCy_T116 spaCy_T113 punct ",",at
spaCy_R117 spaCy_T117 spaCy_T113 advmod respectively,at
spaCy_R118 spaCy_T118 spaCy_T113 punct (,at
spaCy_R119 spaCy_T119 spaCy_T113 prep P,at
spaCy_R12 spaCy_T12 spaCy_T13 amod diabetic,patients
spaCy_R120 spaCy_T120 spaCy_T122 amod less,0.05
spaCy_R121 spaCy_T121 spaCy_T122 quantmod than,0.05
spaCy_R122 spaCy_T122 spaCy_T119 nummod 0.05,P
spaCy_R123 spaCy_T123 spaCy_T119 punct ),P
spaCy_R124 spaCy_T124 spaCy_T62 punct .,had
spaCy_R125 spaCy_T125 spaCy_T141 nmod Basal,levels
spaCy_R126 spaCy_T126 spaCy_T127 punct (,P
spaCy_R127 spaCy_T127 spaCy_T125 appos P,Basal
spaCy_R128 spaCy_T128 spaCy_T130 amod less,0.05
spaCy_R129 spaCy_T129 spaCy_T130 quantmod than,0.05
spaCy_R13 spaCy_T13 spaCy_T10 pobj patients,in
spaCy_R130 spaCy_T130 spaCy_T127 appos 0.05,P
spaCy_R131 spaCy_T131 spaCy_T127 punct ),P
spaCy_R132 spaCy_T132 spaCy_T125 cc and,Basal
spaCy_R133 spaCy_T133 spaCy_T125 conj MTC-stimulated,Basal
spaCy_R134 spaCy_T134 spaCy_T140 punct (,PRL
spaCy_R135 spaCy_T135 spaCy_T140 nmod P,PRL
spaCy_R136 spaCy_T136 spaCy_T138 amod less,0.05
spaCy_R137 spaCy_T137 spaCy_T138 quantmod than,0.05
spaCy_R138 spaCy_T138 spaCy_T135 nummod 0.05,P
spaCy_R139 spaCy_T139 spaCy_T140 punct ),PRL
spaCy_R14 spaCy_T14 spaCy_T13 prep with,patients
spaCy_R140 spaCy_T140 spaCy_T141 compound PRL,levels
spaCy_R141 spaCy_T141 spaCy_T142 nsubj levels,were
spaCy_R142 spaCy_T142 spaCy_T142 ROOT were,were
spaCy_R143 spaCy_T143 spaCy_T142 acomp lower,were
spaCy_R144 spaCy_T144 spaCy_T143 prep in,lower
spaCy_R145 spaCy_T145 spaCy_T144 pobj DMAM,in
spaCy_R146 spaCy_T146 spaCy_T143 prep than,lower
spaCy_R147 spaCy_T147 spaCy_T146 prep in,than
spaCy_R148 spaCy_T148 spaCy_T149 compound DM,patients
spaCy_R149 spaCy_T149 spaCy_T147 pobj patients,in
spaCy_R15 spaCy_T15 spaCy_T14 pobj amenorrhea,with
spaCy_R150 spaCy_T150 spaCy_T142 punct .,were
spaCy_R151 spaCy_T151 spaCy_T152 compound Serum,PRL
spaCy_R152 spaCy_T152 spaCy_T155 nsubj PRL,increased
spaCy_R153 spaCy_T153 spaCy_T152 cc and,PRL
spaCy_R154 spaCy_T154 spaCy_T152 conj FSH,PRL
spaCy_R155 spaCy_T155 spaCy_T155 ROOT increased,increased
spaCy_R156 spaCy_T156 spaCy_T155 advmod significantly,increased
spaCy_R157 spaCy_T157 spaCy_T163 punct (,in
spaCy_R158 spaCy_T158 spaCy_T163 nmod P,in
spaCy_R159 spaCy_T159 spaCy_T161 amod less,0.02
spaCy_R16 spaCy_T16 spaCy_T1 punct .,secretion
spaCy_R160 spaCy_T160 spaCy_T161 quantmod than,0.02
spaCy_R161 spaCy_T161 spaCy_T158 appos 0.02,P
spaCy_R162 spaCy_T162 spaCy_T163 punct ),in
spaCy_R163 spaCy_T163 spaCy_T155 prep in,increased
spaCy_R164 spaCy_T164 spaCy_T166 nummod six,patients
spaCy_R165 spaCy_T165 spaCy_T166 compound DMAM,patients
spaCy_R166 spaCy_T166 spaCy_T163 pobj patients,in
spaCy_R167 spaCy_T167 spaCy_T155 prep during,increased
spaCy_R168 spaCy_T168 spaCy_T169 nummod 10,weeks
spaCy_R169 spaCy_T169 spaCy_T167 pobj weeks,during
spaCy_R17 spaCy_T17 spaCy_T19 det The,influence
spaCy_R170 spaCy_T170 spaCy_T169 prep of,weeks
spaCy_R171 spaCy_T171 spaCy_T173 amod oral,administration
spaCy_R172 spaCy_T172 spaCy_T173 compound MTC,administration
spaCy_R173 spaCy_T173 spaCy_T170 pobj administration,of
spaCy_R174 spaCy_T174 spaCy_T155 punct ",",increased
spaCy_R175 spaCy_T175 spaCy_T185 mark whereas,occurred
spaCy_R176 spaCy_T176 spaCy_T184 det no,alterations
spaCy_R177 spaCy_T177 spaCy_T184 amod significant,alterations
spaCy_R178 spaCy_T178 spaCy_T179 punct (,P
spaCy_R179 spaCy_T179 spaCy_T184 nmod P,alterations
spaCy_R18 spaCy_T18 spaCy_T19 amod dopaminergic,influence
spaCy_R180 spaCy_T180 spaCy_T182 amod greater,0.05
spaCy_R181 spaCy_T181 spaCy_T182 quantmod than,0.05
spaCy_R182 spaCy_T182 spaCy_T179 nummod 0.05,P
spaCy_R183 spaCy_T183 spaCy_T184 punct ),alterations
spaCy_R184 spaCy_T184 spaCy_T185 nsubj alterations,occurred
spaCy_R185 spaCy_T185 spaCy_T155 advcl occurred,increased
spaCy_R186 spaCy_T186 spaCy_T185 prep in,occurred
spaCy_R187 spaCy_T187 spaCy_T186 pobj serum,in
spaCy_R188 spaCy_T188 spaCy_T191 nmod LH,levels
spaCy_R189 spaCy_T189 spaCy_T188 cc and,LH
spaCy_R19 spaCy_T19 spaCy_T39 nsubjpass influence,studied
spaCy_R190 spaCy_T190 spaCy_T191 compound estradiol,levels
spaCy_R191 spaCy_T191 spaCy_T185 dobj levels,occurred
spaCy_R192 spaCy_T192 spaCy_T155 punct .,increased
spaCy_R193 spaCy_T193 spaCy_T195 det These,point
spaCy_R194 spaCy_T194 spaCy_T195 compound data,point
spaCy_R195 spaCy_T195 spaCy_T195 ROOT point,point
spaCy_R196 spaCy_T196 spaCy_T195 prep toward,point
spaCy_R197 spaCy_T197 spaCy_T199 amod increased,activity
spaCy_R198 spaCy_T198 spaCy_T199 amod dopaminergic,activity
spaCy_R199 spaCy_T199 spaCy_T196 pobj activity,toward
spaCy_R2 spaCy_T2 spaCy_T1 prep before,secretion
spaCy_R20 spaCy_T20 spaCy_T19 prep on,influence
spaCy_R200 spaCy_T200 spaCy_T199 prep in,activity
spaCy_R201 spaCy_T201 spaCy_T202 compound DMAM,patients
spaCy_R202 spaCy_T202 spaCy_T200 pobj patients,in
spaCy_R203 spaCy_T203 spaCy_T195 punct .,point
spaCy_R21 spaCy_T21 spaCy_T22 amod luteinizing,hormone
spaCy_R22 spaCy_T22 spaCy_T20 pobj hormone,on
spaCy_R23 spaCy_T23 spaCy_T22 punct (,hormone
spaCy_R24 spaCy_T24 spaCy_T22 appos LH,hormone
spaCy_R25 spaCy_T25 spaCy_T22 punct ),hormone
spaCy_R26 spaCy_T26 spaCy_T22 punct ",",hormone
spaCy_R27 spaCy_T27 spaCy_T28 amod follicle-stimulating,hormone
spaCy_R28 spaCy_T28 spaCy_T22 appos hormone,hormone
spaCy_R29 spaCy_T29 spaCy_T28 punct (,hormone
spaCy_R3 spaCy_T3 spaCy_T2 cc and,before
spaCy_R30 spaCy_T30 spaCy_T28 appos FSH,hormone
spaCy_R31 spaCy_T31 spaCy_T28 punct ),hormone
spaCy_R32 spaCy_T32 spaCy_T22 punct ",",hormone
spaCy_R33 spaCy_T33 spaCy_T22 cc and,hormone
spaCy_R34 spaCy_T34 spaCy_T22 conj prolactin,hormone
spaCy_R35 spaCy_T35 spaCy_T34 punct (,prolactin
spaCy_R36 spaCy_T36 spaCy_T34 appos PRL,prolactin
spaCy_R37 spaCy_T37 spaCy_T34 punct ),prolactin
spaCy_R38 spaCy_T38 spaCy_T39 auxpass was,studied
spaCy_R39 spaCy_T39 spaCy_T39 ROOT studied,studied
spaCy_R4 spaCy_T4 spaCy_T2 conj during,before
spaCy_R40 spaCy_T40 spaCy_T39 prep in,studied
spaCy_R41 spaCy_T41 spaCy_T43 nummod 12,patients
spaCy_R42 spaCy_T42 spaCy_T43 amod diabetic,patients
spaCy_R43 spaCy_T43 spaCy_T40 pobj patients,in
spaCy_R44 spaCy_T44 spaCy_T43 prep with,patients
spaCy_R45 spaCy_T45 spaCy_T44 pobj amenorrhea,with
spaCy_R46 spaCy_T46 spaCy_T43 punct (,patients
spaCy_R47 spaCy_T47 spaCy_T43 appos DMAM,patients
spaCy_R48 spaCy_T48 spaCy_T43 punct ),patients
spaCy_R49 spaCy_T49 spaCy_T40 cc and,in
spaCy_R5 spaCy_T5 spaCy_T9 amod acute,blockade
spaCy_R50 spaCy_T50 spaCy_T40 conj in,in
spaCy_R51 spaCy_T51 spaCy_T55 nummod 10,patients
spaCy_R52 spaCy_T52 spaCy_T55 amod normal,patients
spaCy_R53 spaCy_T53 spaCy_T55 compound menstruating,patients
spaCy_R54 spaCy_T54 spaCy_T55 compound diabetic,patients
spaCy_R55 spaCy_T55 spaCy_T50 pobj patients,in
spaCy_R56 spaCy_T56 spaCy_T55 punct (,patients
spaCy_R57 spaCy_T57 spaCy_T55 appos DM,patients
spaCy_R58 spaCy_T58 spaCy_T55 punct ),patients
spaCy_R59 spaCy_T59 spaCy_T39 punct .,studied
spaCy_R6 spaCy_T6 spaCy_T5 cc and,acute
spaCy_R60 spaCy_T60 spaCy_T61 compound DMAM,patients
spaCy_R61 spaCy_T61 spaCy_T62 nsubj patients,had
spaCy_R62 spaCy_T62 spaCy_T62 ROOT had,had
spaCy_R63 spaCy_T63 spaCy_T64 det a,reduction
spaCy_R64 spaCy_T64 spaCy_T62 dobj reduction,had
spaCy_R65 spaCy_T65 spaCy_T64 prep in,reduction
spaCy_R66 spaCy_T66 spaCy_T67 compound LH,pulsatility
spaCy_R67 spaCy_T67 spaCy_T65 pobj pulsatility,in
spaCy_R68 spaCy_T68 spaCy_T69 punct (,P
spaCy_R69 spaCy_T69 spaCy_T67 appos P,pulsatility
spaCy_R7 spaCy_T7 spaCy_T5 conj chronic,acute
spaCy_R70 spaCy_T70 spaCy_T72 amod less,0.05
spaCy_R71 spaCy_T71 spaCy_T72 quantmod than,0.05
spaCy_R72 spaCy_T72 spaCy_T69 nummod 0.05,P
spaCy_R73 spaCy_T73 spaCy_T69 punct ),P
spaCy_R74 spaCy_T74 spaCy_T67 cc and,pulsatility
spaCy_R75 spaCy_T75 spaCy_T77 amod basal,levels
spaCy_R76 spaCy_T76 spaCy_T77 compound LH,levels
spaCy_R77 spaCy_T77 spaCy_T67 conj levels,pulsatility
spaCy_R78 spaCy_T78 spaCy_T77 punct (,levels
spaCy_R79 spaCy_T79 spaCy_T77 appos P,levels
spaCy_R8 spaCy_T8 spaCy_T9 compound dopamine-receptor,blockade
spaCy_R80 spaCy_T80 spaCy_T82 amod less,0.02
spaCy_R81 spaCy_T81 spaCy_T82 quantmod than,0.02
spaCy_R82 spaCy_T82 spaCy_T79 nummod 0.02,P
spaCy_R83 spaCy_T83 spaCy_T79 punct ),P
spaCy_R84 spaCy_T84 spaCy_T77 punct ",",levels
spaCy_R85 spaCy_T85 spaCy_T62 prep compared,had
spaCy_R86 spaCy_T86 spaCy_T85 prep with,compared
spaCy_R87 spaCy_T87 spaCy_T88 compound DM,patients
spaCy_R88 spaCy_T88 spaCy_T86 pobj patients,with
spaCy_R89 spaCy_T89 spaCy_T62 punct ",",had
spaCy_R9 spaCy_T9 spaCy_T4 pobj blockade,during
spaCy_R90 spaCy_T90 spaCy_T92 mark whereas,had
spaCy_R91 spaCy_T91 spaCy_T92 nsubj they,had
spaCy_R92 spaCy_T92 spaCy_T62 advcl had,had
spaCy_R93 spaCy_T93 spaCy_T97 det an,response
spaCy_R94 spaCy_T94 spaCy_T97 nmod LH,response
spaCy_R95 spaCy_T95 spaCy_T94 cc and,LH
spaCy_R96 spaCy_T96 spaCy_T94 conj FSH,LH
spaCy_R97 spaCy_T97 spaCy_T92 dobj response,had
spaCy_R98 spaCy_T98 spaCy_T97 prep to,response
spaCy_R99 spaCy_T99 spaCy_T100 amod intravenous,metoclopramide